These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 5106567)

  • 1. Neuropharmacological studies of imidazole-4-acetic acid actions in the mouse and rat.
    Marcus RJ; Winters WD; Roberts E; Simonsen DG
    Neuropharmacology; 1971 Mar; 10(21):203-15. PubMed ID: 5106567
    [No Abstract]   [Full Text] [Related]  

  • 2. Behavioural interactions between imidazoleacetic acid and gamma-hydroxybutyric acid in rats and mice.
    Benton D; Kyriacou CP; Rick JT; Taberner PV
    Eur J Pharmacol; 1974 Aug; 27(3):288-93. PubMed ID: 4425346
    [No Abstract]   [Full Text] [Related]  

  • 3. The central action of gamma-butyrolactone and gamma-hydroxybutyrate.
    Ban T; Takaori S; Sasa M; Shimamoto K
    Jpn J Pharmacol; 1967 Mar; 17(1):30-45. PubMed ID: 5299973
    [No Abstract]   [Full Text] [Related]  

  • 4. Central nervous system depressants. 10. 1-Carbamoylbenzodiazepines.
    Moffett RB; Rudzik AD
    J Med Chem; 1972 Oct; 15(10):1079-81. PubMed ID: 5069780
    [No Abstract]   [Full Text] [Related]  

  • 5. Central nervous system depressants. 11. Benzodiazepines with ureas in the 2 position.
    Moffett RB; Rudzik AD
    J Med Chem; 1973 Nov; 16(11):1256-60. PubMed ID: 4747967
    [No Abstract]   [Full Text] [Related]  

  • 6. Stereostructure-activity relationships for oxazepam hemisuccinate. Effects on central nervous system.
    de Angelis L; Predominato M; Vertua R
    Arzneimittelforschung; 1972 Aug; 22(8):1328-33. PubMed ID: 4678394
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative evaluation of the central nervous system activity of diazepam and its metabolites (demethyl-diazepam, methyl-oxazepam and oxazepam).
    de Angelis L; Traversa U; Vertua R
    Pharmacol Res Commun; 1974 Feb; 6(1):61-75. PubMed ID: 4427921
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on some aspects of the neuropharmacology of butylurea.
    Dar MS; Fakouhi T
    Arch Int Pharmacodyn Ther; 1974 Apr; 208(2):204-12. PubMed ID: 4854473
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacological properties of substituted gamma-butyrolactones. I. The effects on the central nervous system.
    Sieroslawska J; Hano J; Sypniewska M; Czarnecki R; Chojnacka-Wójcik E; Harasiewicz A
    Pol J Pharmacol Pharm; 1973; 25(1):1-16. PubMed ID: 4798097
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative effects of chlorpromazine hydrochloride and quaternary chlorpromazine hydrochloride on the central nervous systems of rats and mice.
    Watzman N; Manian AA; Barry H; Buckley JP
    J Pharm Sci; 1968 Dec; 57(12):2089-93. PubMed ID: 5708349
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of alkylamides of glutamic acid and related compounds on the central nervous system. I. Central depressant effect of theanine.
    Kimura R; Murata T
    Chem Pharm Bull (Tokyo); 1971 Jun; 19(6):1257-61. PubMed ID: 4397636
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experimental study of the pharmacological effect of oxyphenamate].
    Gorshkova VK; Mikhaĭlova TV; Gilev AP
    Farmakol Toksikol; 1970; 33(3):264-7. PubMed ID: 5465696
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and pharmacological activity of dialkylaminoethyl esters and amides of phenylmercaptoacetic acid and its derivatives.
    Tsatsas G; Costakis E; Benson W; Ferguson SA
    J Med Chem; 1971 Oct; 14(10):1004-5. PubMed ID: 5115677
    [No Abstract]   [Full Text] [Related]  

  • 14. Denzimol, a new anticonvulsant drug. I. General anticonvulsant profile.
    Graziani G; Tirone F; Barbadoro E; Testa R
    Arzneimittelforschung; 1983; 33(8):1155-60. PubMed ID: 6685493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoquinolines. 3. 3-Aminoisoquinoline derivatives with central nervous system depressant activity.
    Neumeyer JL; Weinhardt KK; Carrano RA; McCurdy DH
    J Med Chem; 1973 Jul; 16(7):808-13. PubMed ID: 4725927
    [No Abstract]   [Full Text] [Related]  

  • 16. Synergism by atropine of central stimulant properties of phenylpropanolamine.
    Davis WM; Pinkerton JT
    Toxicol Appl Pharmacol; 1972 May; 22(1):138-45. PubMed ID: 5034981
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of gamma-hydroxybutyrate on chick behaviour, electrocortical activity and crossed extensor reflexes.
    Osuide G
    Br J Pharmacol; 1972 Apr; 44(4):593-604. PubMed ID: 4402818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cataleptic state induced by ketamine: a review of the neuropharmacology of anesthesia.
    Winters WD; Ferrar-Allado T; Guzman-Flores C; Alcaraz M
    Neuropharmacology; 1972 May; 11(3):303-15. PubMed ID: 5065715
    [No Abstract]   [Full Text] [Related]  

  • 19. Animal studies comparing the neuropharmacological profile of a trifluoperazine HCl-amobarbital combination with that of the individual components.
    Wardell JR; Staples RG
    Arch Int Pharmacodyn Ther; 1969 May; 179(1):106-20. PubMed ID: 5348387
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological interactions between -hydroxybutyric acid and agents which modify cerebral -aminobutyric acid (GABA) metabolism.
    Benton D; Rick JT; Taberner PV
    Br J Pharmacol; 1973 Mar; 47(3):648P-649P. PubMed ID: 4730861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.